Clinical Trial Update: Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis [Phase 4]

View source ↗

Summary

A Phase 4 trial update evaluating the efficacy and safety of telmisartan in hypertensive patients with varying renal impairment, including those on hemodialysis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hypertension

Drugs mentioned

• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED